Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood

Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood

Down syndrome (DS) is a common chromosomal abnormality occurring in about 1 in 700 live births. The gene encoding for Cu-Zn superoxide dismutase (SOD) is present on chromosome 21, thus, individuals with triplicates of this chromosome are postulated to be in a state of oxidative stress. Previously, i...

Full description

Saved in:
Bibliographic Details
Main Author: Mahamood, Maziana
Format: Thesis
Language:English
Published: 2023
Subjects:
Vitamins
Online Access:https://ir.uitm.edu.my/id/eprint/74319/2/74319.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-uitm-ir.74319
record_format uketd_dc
spelling my-uitm-ir.743192024-01-15T03:05:46Z Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood 2023 Mahamood, Maziana Vitamins Neuroscience. Biological psychiatry. Neuropsychiatry Down syndrome (DS) is a common chromosomal abnormality occurring in about 1 in 700 live births. The gene encoding for Cu-Zn superoxide dismutase (SOD) is present on chromosome 21, thus, individuals with triplicates of this chromosome are postulated to be in a state of oxidative stress. Previously, it was shown that DS was associated with oxidative stress and impairment of immune function. It is postulated that the supplementation with tocotrienol rich fraction (TRF) (150 mg) and vitamin C (500 mg) will relieve DS subjects from oxidative stress i.e the improvement of the DNA damage levels, antioxidant-oxidative stress status, plasma levels of vitamin C and E and miRNA levels. This study aimed to examine the molecular mechanism of TRF and vitamin C to combat oxidative stress in DS. This was a cross-sectional study carried out with informed consent on DS subjectsfrom several Pusat Pemulihan Dalam Komuniti (PDK) in Klang Valley after ethical approval was obtained. The demographic data of the study participants were gathered through questionnaires that were distributed to parents. Sixty DS subjects (2 to 29 years old) were recruited and randomly assigned to receive either supplementation (n=30) with TRF (150 mg) and vitamin C (500 mg) or placebo (n=30), daily for 6 months. Blood samples were obtained from each subject at 0, 3rd and 6th months for the analysis. Antioxidant-oxidative stress status was assessed from the measurement of antioxidant enzyme activities in erythrocytes, viz, SOD, catalase (CAT) and glutathione peroxidase (GPx). DNA damage was measured using comet assay and 8-hydroxy-2’-deoxyguanosine (8-OHdG) level was evaluated using ELISA to measure the endogenous oxidative damage to DNA. The 8-isoprostane level was measured to study the biomarker of oxidative stress. Vitamin C and E levels were assessed using HPLC and miRNA analysis was performed using RT-PCR. This study showed the activities of antioxidant enzymes of DS subjects after supplementation with TRF and vitamin C were similar when comparing the baseline to 3 and 6 months (p>0.05). There were no associations between SOD, CAT and GPx activities and plasma level of vitamin C and E in treatment and control groups (p>0.05). There were no significant differences in the comet assay in treatment and control groups at 0, 3 and 6 months of supplementation (p>0.05). Increased plasma level of total vitamin E concentrations was observed with the duration of treatment, after 3 months (9.45±0.58 g/mol, p0.05) in the expression compared to baseline at 0 month. A significantly upregulated expression of hsa-miR-99a (2.40±0.08 folds, p=0.044) and hsa-miR-802a (3.60±0.041 folds, p=0.022) were seen compared to controls after 3 months of intervention. A significantly upregulated expression of hsa-miR-99a (2.58±0.04 folds, p=0.049) and downregulated expression of hsa-miR-125b (3.51±0.01 folds, p=0.049) were found compared to controls at 6 months of intervention. In conclusion, daily supplementation with TRF (150 mg) and vitamin C (500 mg) for 6 months did not improve the oxidative stress level in DS subjects. Factors such as the duration of supplementation and the number of subjects should be addressed in future studies. Other factors such as genetic, epigenetic, and environmental may play a role in how the DS phenotype specifically that related to oxidative stress expresses itself in each individual. 2023 Thesis https://ir.uitm.edu.my/id/eprint/74319/ https://ir.uitm.edu.my/id/eprint/74319/2/74319.pdf text en public phd doctoral Universiti Teknologi MARA (UiTM) Faculty of Pharmacy Adam, Aishah Hasan, Mizaton Hazizul Mohd Ismail, Nafeeza Ahsan, Kazi Zainal Abidin, Anis Siham Noordin, Mazidah Mohd Nor, Noor Shafina Mohd Rana, Norashikin Abu, Nor Azizah Basri, Mohd Azahari
institution Universiti Teknologi MARA
collection UiTM Institutional Repository
language English
advisor Adam, Aishah
Hasan, Mizaton Hazizul
Mohd Ismail, Nafeeza
Ahsan, Kazi
Zainal Abidin, Anis Siham
Noordin, Mazidah
Mohd Nor, Noor Shafina
Mohd Rana, Norashikin
Abu, Nor Azizah
Basri, Mohd Azahari
topic Vitamins
Vitamins
spellingShingle Vitamins
Vitamins
Mahamood, Maziana
Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood
description Down syndrome (DS) is a common chromosomal abnormality occurring in about 1 in 700 live births. The gene encoding for Cu-Zn superoxide dismutase (SOD) is present on chromosome 21, thus, individuals with triplicates of this chromosome are postulated to be in a state of oxidative stress. Previously, it was shown that DS was associated with oxidative stress and impairment of immune function. It is postulated that the supplementation with tocotrienol rich fraction (TRF) (150 mg) and vitamin C (500 mg) will relieve DS subjects from oxidative stress i.e the improvement of the DNA damage levels, antioxidant-oxidative stress status, plasma levels of vitamin C and E and miRNA levels. This study aimed to examine the molecular mechanism of TRF and vitamin C to combat oxidative stress in DS. This was a cross-sectional study carried out with informed consent on DS subjectsfrom several Pusat Pemulihan Dalam Komuniti (PDK) in Klang Valley after ethical approval was obtained. The demographic data of the study participants were gathered through questionnaires that were distributed to parents. Sixty DS subjects (2 to 29 years old) were recruited and randomly assigned to receive either supplementation (n=30) with TRF (150 mg) and vitamin C (500 mg) or placebo (n=30), daily for 6 months. Blood samples were obtained from each subject at 0, 3rd and 6th months for the analysis. Antioxidant-oxidative stress status was assessed from the measurement of antioxidant enzyme activities in erythrocytes, viz, SOD, catalase (CAT) and glutathione peroxidase (GPx). DNA damage was measured using comet assay and 8-hydroxy-2’-deoxyguanosine (8-OHdG) level was evaluated using ELISA to measure the endogenous oxidative damage to DNA. The 8-isoprostane level was measured to study the biomarker of oxidative stress. Vitamin C and E levels were assessed using HPLC and miRNA analysis was performed using RT-PCR. This study showed the activities of antioxidant enzymes of DS subjects after supplementation with TRF and vitamin C were similar when comparing the baseline to 3 and 6 months (p>0.05). There were no associations between SOD, CAT and GPx activities and plasma level of vitamin C and E in treatment and control groups (p>0.05). There were no significant differences in the comet assay in treatment and control groups at 0, 3 and 6 months of supplementation (p>0.05). Increased plasma level of total vitamin E concentrations was observed with the duration of treatment, after 3 months (9.45±0.58 g/mol, p0.05) in the expression compared to baseline at 0 month. A significantly upregulated expression of hsa-miR-99a (2.40±0.08 folds, p=0.044) and hsa-miR-802a (3.60±0.041 folds, p=0.022) were seen compared to controls after 3 months of intervention. A significantly upregulated expression of hsa-miR-99a (2.58±0.04 folds, p=0.049) and downregulated expression of hsa-miR-125b (3.51±0.01 folds, p=0.049) were found compared to controls at 6 months of intervention. In conclusion, daily supplementation with TRF (150 mg) and vitamin C (500 mg) for 6 months did not improve the oxidative stress level in DS subjects. Factors such as the duration of supplementation and the number of subjects should be addressed in future studies. Other factors such as genetic, epigenetic, and environmental may play a role in how the DS phenotype specifically that related to oxidative stress expresses itself in each individual.
format Thesis
qualification_name Doctor of Philosophy (PhD.)
qualification_level Doctorate
author Mahamood, Maziana
author_facet Mahamood, Maziana
author_sort Mahamood, Maziana
title Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood
title_short Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood
title_full Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood
title_fullStr Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood
title_full_unstemmed Molecular mechanisms of tocotrienol-rich fraction and vitamin C in ameliorating oxidative stress in down syndrome / Maziana Mahamood
title_sort molecular mechanisms of tocotrienol-rich fraction and vitamin c in ameliorating oxidative stress in down syndrome / maziana mahamood
granting_institution Universiti Teknologi MARA (UiTM)
granting_department Faculty of Pharmacy
publishDate 2023
url https://ir.uitm.edu.my/id/eprint/74319/2/74319.pdf
_version_ 1794191897921585152

Similar Items